STOCK TITAN

Revel Michel (NCEL) discloses NewcelX share and option stakes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

NewcelX Ltd. CSO and director Revel Michel filed an initial ownership report. He directly holds 940,787 ordinary shares and options on 9,117 ordinary shares at an exercise price of $7.6200 expiring on November 4, 2035. As of this filing, 759 option shares are vested and exercisable, with the remainder vesting in 11 equal quarterly installments beginning May 4, 2026, subject to his continued service. Certain option grants are held through a trustee to qualify for Israeli tax benefits under Section 102 of the Israeli Tax Ordinance.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Revel Michel

(Last)(First)(Middle)
C/O NEWCELX LTD.
THE CIRCLE 6

(Street)
ZURICH8058

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
NewcelX Ltd. [ NCEL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CSO and Director
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares940,787D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Ordinary Shares (1)11/04/2035Ordinary Shares9,117(2)$7.62D
Explanation of Responses:
1. As of the date of this Form 3, options to purchase 759 ordinary shares are vested and currently exercisable. The remaining options vest and become exercisable beginning on May 4, 2026 in 11 equal installments on a quarterly basis, subject to the Reporting Person's continued service.
2. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in the name of a trustee.
/s/ Michel Revel03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Revel Michel’s Form 3 filing for NewcelX Ltd. (NCEL) show?

The Form 3 shows CSO and director Revel Michel’s initial ownership in NewcelX. He holds 940,787 ordinary shares directly plus options on 9,117 ordinary shares, providing a detailed snapshot of his equity stake at the reporting date.

How many NewcelX (NCEL) shares does Revel Michel directly own?

Revel Michel directly owns 940,787 ordinary shares of NewcelX. This direct holding reflects his current equity position in the company’s ordinary shares as reported in the Form 3, separate from any options or other derivative securities.

What stock options does Revel Michel hold in NewcelX (NCEL)?

He holds options to purchase 9,117 NewcelX ordinary shares at an exercise price of $7.6200, expiring November 4, 2035. These options give him the right, but not obligation, to buy additional shares at that price before expiration.

How are Revel Michel’s NewcelX (NCEL) options vesting over time?

As of the Form 3 date, options for 759 ordinary shares are vested and exercisable. The remaining options vest in 11 equal quarterly installments beginning May 4, 2026, conditional on his continued service with NewcelX throughout the vesting period.

Why are some NewcelX (NCEL) options held through a trustee for Revel Michel?

To qualify for tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in a trustee’s name, so certain options are held by a trustee on his behalf.
NewcelX Ltd

NASDAQ:NCEL

View NCEL Stock Overview

NCEL Rankings

NCEL Latest News

NCEL Latest SEC Filings

NCEL Stock Data

11.03M
1.31M
Biotechnology
Healthcare
Link
Switzerland
Zurich